[[File{{Drugswitch | from = vortioxetine | to = fluvoxamine| stop = {{stopVortioxetine}}| start = * '''Day 8:Empty''' start administration of fluvoxamine in a dosage of 50 mg/day.jpg]]{{Day22NoBloodlevelvortioxetine}}<ref name="vortiswitch"> {{Pubmed|24570588 |Katona et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. 2014 2014 Feb 19;10:349-54}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref>| info = * {{theorSS}}* Fluvoxamine is a inhibitor of CYP2C9, which metabolizes vortioxetine. }}
